Steere A C, Levin R E, Molloy P J, Kalish R A, Abraham J H, Liu N Y, Schmid C H
New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts.
Arthritis Rheum. 1994 Jun;37(6):878-88. doi: 10.1002/art.1780370616.
To test treatment regimens for Lyme arthritis.
Patients were randomly assigned to treatment with doxycycline or amoxicillin plus probenecid for 30 days. Patients who had persistent arthritis for at least 3 months after treatment with oral antibiotics or parenteral penicillin were given intravenous ceftriaxone for 2 weeks.
Eighteen of the 20 patients treated with doxycycline and 16 of the 18 patients who completed the amoxicillin regimen had resolution of the arthritis within 1-3 months after study entry. However, neuroborreliosis later developed in 5 patients, 4 of whom had received the amoxicillin regimen. Of 16 patients (2 from the oral antibiotic study and 14 additional patients) who had persistent arthritis despite previous oral antibiotics or parenteral penicillin, none had resolution of the arthritis within 3 months after ceftriaxone therapy. The HLA-DR4 specificity and OspA reactivity were associated with a lack of response.
Lyme arthritis can usually be treated successfully with oral antibiotics, but patients may still develop neuroborreliosis. Patients with certain genetic and immune markers may have persistent arthritis despite treatment with oral or intravenous antibiotics.
测试莱姆关节炎的治疗方案。
患者被随机分配接受强力霉素或阿莫西林加丙磺舒治疗30天。在接受口服抗生素或胃肠外青霉素治疗后持续关节炎至少3个月的患者,给予静脉注射头孢曲松2周。
在接受强力霉素治疗的20例患者中,18例在研究开始后1至3个月内关节炎得到缓解;在完成阿莫西林治疗方案的18例患者中,16例有同样效果。然而,5例患者后来发生了神经型莱姆病,其中4例接受了阿莫西林治疗方案。在16例尽管先前接受过口服抗生素或胃肠外青霉素治疗仍患有持续性关节炎的患者(2例来自口服抗生素研究,另有14例患者)中,在头孢曲松治疗后3个月内无人关节炎得到缓解。HLA-DR4特异性和OspA反应性与无反应相关。
莱姆关节炎通常可用口服抗生素成功治疗,但患者仍可能发生神经型莱姆病。具有某些遗传和免疫标志物的患者尽管接受口服或静脉抗生素治疗,仍可能患有持续性关节炎。